PatientsVille.com Logo

PatientsVille

Dextrose Side Effects

Report Dextrose Side Effects

Examples: headache, dizziness


The most commonly reported Dextrose side effects are:
Stomach Fat (11 reports)
Migraines (6 reports)
Is It Bad For You (3 reports)
Nose (3 reports)
Stiff (2 reports)
Feet (1 reports)
I Have A Really Bad Reaction To All Artificial Swe (1 reports)
I Have A Really Bad Reaction To All Artificial Swe (1 reports)
If I Eat Or Drink Anything With Aspertame I Get Re (1 reports)
Legs (1 reports)
Sleepiness (1 reports)
They Are Are So Bad For Us. (1 reports)

If you have experienced a side effect listed above, you can check a box to report it.


View a complete list of Dextrose side effects or compare Dextrose side effects

If you or someone in your family has experienced a serious side effect to a health product, you are encouraged to report the experience to your health care professional (eg, physician, pharmacist). Your health care provider can provide additional clinical information and complete a copy of the side effect reporting form.

Side effects reports are analyzed to discover potential health product safety signals. Some important reactions may take an extremely long time to develop or occur infrequently. Continued monitoring of adverse reactions is thus essential to maintain a comprehensive safety and effectiveness profile of health products.

Dextrose Side Effects Reported to FDA

The following Dextrose reports list potential signals of serious risks and new safety information that were identified using the FDA Adverse Event Reporting System (FAERS).
FAERS is a database that contains information on adverse event and medication errors reports submitted to FDA by healthcare professionals (such as physicians, pharmacists, nurses and others), consumers (such as patients, family members, layers and others) and manufacturers.


The appearance of Dextrose on this list does not mean that FDA has concluded that the drug has the listed risk. It means that FDA has identified a potential safety issue, but it does not mean that FDA has found a causal relationship between the drug and the listed risk.
Febrile Neutropenia
on Jun 06, 2012 Female from UNITED STATES , 45 years of age, was treated with Dextrose. Directly after, patient experienced the unwanted or unexpected Dextrose side effects: febrile neutropenia. Dextrose dosage: 12.5 G, Unk.
Associated medications used:
  • Diphenhydramine Hcl (12.5 Mg, Unk)
  • Hydromorphone Hcl (0.5 Mg, Unk)
  • Potassium Phosphates (30 Mmol, Qd)
  • Docusate Sodium (2 Df, Bid)
  • Acetaminophen (650 Mg, Q8h)
  • Lorazepam (Unk Unk, Q8h)
  • Potassium Chloride (40 Meq, Qd)
  • Rosuvastatin (5 Mg, Unk)


Hypophagia, Nausea
Patient was taking Dextrose 5% And Sodium Chloride 0.45% In Plastic Container. Patient felt the following Dextrose side effects: hypophagia, nausea on May 16, 2012 from UNITED STATES Additional patient health information: Female , weighting 116.4 lb, was diagnosed with and. Dextrose 5% And Sodium Chloride 0.45% In Plastic Container dosage: 1000 Ml, Unk.
Multiple prescriptions taken:
  • Exalgo (4 Mg, Qd)
  • Muteran (3 Doses)
  • Neurontin (3 Doses)
  • Janumet (2 Doses)
  • Humulin N (8 Iu, Unk)
  • Gasmotin (3 Doses)
  • Exalgo (4 Mg, Qd)
  • Gasmotin
Patient was hospitalized.

Chills, Convulsion, Hyperpyrexia
Adverse event was reported on May 11, 2012 by a Male taking Dextrose 5% And Electrolyte No.48 In Plastic Container (Dosage: N/A) . Location: INDIA , child 2 years of age, After Dextrose was administered, patient encountered several Dextrose side effects: chills, convulsion, hyperpyrexia. Patient was hospitalized.

Speech Disorder, Dysarthria
on May 03, 2012 Female from UNITED STATES , weighting 112.7 lb, was treated with Dextrose 5%. Directly after, patient experienced the unwanted or unexpected Dextrose side effects: speech disorder, dysarthria. Dextrose 5% dosage: N/A.
Associated medications used:
  • Oxaliplatin (|dosagetext: 125 Mg/500 Ml D5w||route: Intravenous Drip|)



Feeding Disorder, Somnolence
on Mar 30, 2012 Male from JAPAN , weighting 7.50 lb, was treated with Dextrose 50%. Patient felt the following Dextrose side effects: feeding disorder, somnolence. Dextrose 50% dosage: N/A.
Multiple prescriptions taken:
  • Seroquel
  • Zolpidem
  • Depas
  • Kamikihitou
  • Physio
  • 5 % Glucose
  • Rohypnol
  • Lorazepam


Lymphadenopathy, Intervertebral Disc Protrusion, Osteonecrosis, Pertussis, Pain In Extremity, Arthralgia, Back Pain, Fatigue
Patient was taking Dextrose. After Dextrose was administered, patient encountered several Dextrose side effects: lymphadenopathy, intervertebral disc protrusion, osteonecrosis, pertussis, pain in extremity, arthralgia, back pain, fatigue on Mar 21, 2012 from DENMARK Additional patient health information: Female , 17 years of age, . Dextrose dosage: Glucose Monohydrate The Patient Also Received Darrow Glucose Sad Hydration In 24 Hrs Hours.
Multiple concurrent drugs taken:
  • Mesna (3jul06-4sep06 200 Mg Iv; 25sep06-3oct06 230 Mg 03, 10, 31jul; 07, 28aug And 03oct)
  • Cyclophosphamide (3jul06-4sep06 750 Mg Iv; 25sep06-3oct06 775 Mg 1 Hr Infusion On 03, 10, 31jul; 07, 28aug And 03oct)
  • Procarbazine Hydrochloride (Natulanar)
  • Oncovin (Infusion Dates 08,15,22may;5,12,19jun;03,10,31jul;07,28aug;04,11,25sep And 03oct.)
  • Etoposide (Given On May8,9,10,11,12 And Jun5,6,7,8,9 2hr Infusion)
  • Adriamycin Pfs (On 22may,5+19jun 4hr Infusion)
  • Prednisone Tab (08may2006 To 03jul2006 35+25+25 Mg 03jul2006 To 28aug2006 20 Mg X 3)
  • Natriumfluorid


Myalgia, Hyperkalaemia, Myositis, Renal Failure Acute, Arthralgia, Muscular Weakness
Adverse event was reported on Mar 14, 2012 by a Female taking Dextrose (Dosage: Unk Ukn, Unk) . Location: SWITZERLAND , 43 years of age, Directly after, patient experienced the unwanted or unexpected Dextrose side effects: myalgia, hyperkalaemia, myositis, renal failure acute, arthralgia, muscular weakness.
Associated medications used:
  • Sodium Polystyrene Sulfonate (15 Mg, Bid)
  • Sebivo (600 Mg, Unk)
  • Remeron (15 Mg, Unk)
  • Neoral (50 Mg, Unk)
  • Effexor (75 Mg, Unk)
  • Nexium (40 Mg, Unk)
  • Neoral (150 Mg, Unk)
  • Azathioprine Sodium (50 Mg, Unk)
Patient was hospitalized.

Foetal Growth Restriction
on Mar 09, 2012 Patient from CANADA , weighting 4.10 lb, was treated with Dextrose 5% And Sodium Chloride 0.45% In Plastic Container. Patient felt the following Dextrose side effects: foetal growth restriction. Dextrose 5% And Sodium Chloride 0.45% In Plastic Container dosage: Unk.
Multiple prescriptions taken:
  • Acetylsalicylic Acid (Unk)
  • Ondansetron Hcl (Unk)
  • Hydromorphone (Unk)
  • Oxazepam (Unk)
  • Thiamine (100 Mg, Unk)
  • Diphenhydramine (50 Mg, 1 In 6 Hr)
  • Hydroxyzine (100 Mg (25 Mg, 1 In 6 Hr))
  • Cosyntropin (Single Dose)


Electrolyte Imbalance
on Feb 21, 2012 Female from FRANCE , weighting 152.1 lb, was treated with Dextrose. After Dextrose was administered, patient encountered several Dextrose side effects: electrolyte imbalance. Dextrose dosage: Day 1, 8 And 15, 50 Ml Bag Of 5 % Glucose.
Multiple concurrent drugs taken:
  • Kytril (Day 2, 9 And 15)
  • Solu-medrol (Day 1, 8 And 15, Direct Iv Push 30 Min Before Taxaol)
  • Metmab (Last Dose Prior To Sae: 1 Dec 2011)
  • Paclitaxel (Day 1, 8 And 15, 500 Ml Glucose 5 % Iv Over 1 Hour, Last Dose Prior To Sae 01 Dec 2011)
  • Kytril (1 Ampoule, Day 1, 8 And 15)
  • Ranitidine (1 Ampoule,day 1, 8 And 15, Direct Iv Push Over 5 Min 30 Min Before Taxaol,)
  • Vogalene (Day 1-15 Each Month)
  • Avastin (Last Dose Prior To Sae: 1 Dec 2011)
Patient was hospitalized.

Oedema Mouth, Throat Tightness, Heart Rate Increased, Hypertension, Chest Discomfort, Sensation Of Heaviness, Dyspnoea, Local Swelling
Patient was taking Dextrose. Directly after, patient experienced the unwanted or unexpected Dextrose side effects: oedema mouth, throat tightness, heart rate increased, hypertension, chest discomfort, sensation of heaviness, dyspnoea, local swelling on Feb 03, 2012 from AUSTRALIA Additional patient health information: Male , 70 years of age, weighting 149.9 lb, . Dextrose dosage: N/A.
Associated medications used:
  • Capecitabine
  • Dexamethasone
  • Ondansetron
  • Oxaliplatin (130 Mg/m^2 (245 Mg), Intravenous Drip)


Neoplasm Progression
Adverse event was reported on Feb 14, 2012 by a Female taking Dextrose (Dosage: 10 %, Infusion 1 L / 24 H) . Location: FRANCE , 67 years of age, Patient felt the following Dextrose side effects: neoplasm progression.
Multiple prescriptions taken:
  • Sandostatin (100 Ug, Unk)
  • Sandostatin (2000ug/24h)


Tracheal Obstruction, Acidosis Hyperchloraemic
on May 17, 2011 Female from UNITED KINGDOM , 63 years of age, was treated with Dextrose. After Dextrose was administered, patient encountered several Dextrose side effects: tracheal obstruction, acidosis hyperchloraemic. Dextrose dosage: 1 Dose Once Daily.
Multiple concurrent drugs taken:
  • Sodium Chloride (100 Mmol, Daily)
  • Sodium Bicarbonate (1 Dose, Once Daily)
  • Potassium Chloride (1 Dose Once Daily)
  • Sodium Chloride (250 Mmol, Daily)
  • Sodium Chloride (1 Dose, Once Daily)
  • Omeprazole


Pyrexia, Tremor
on Jan 17, 2012 Female from BRAZIL , child 6 years of age, weighting 46.30 lb, was diagnosed with and was treated with Dextrose 5%. Directly after, patient experienced the unwanted or unexpected Dextrose side effects: pyrexia, tremor. Dextrose 5% dosage: N/A. Patient was hospitalized.

Pyrexia, Tremor
Patient was taking Dextrose 5%. Patient felt the following Dextrose side effects: pyrexia, tremor on Jan 17, 2012 from BRAZIL Additional patient health information: Male , child 10 years of age, weighting 85.98 lb, was diagnosed with and. Dextrose 5% dosage: N/A.
Multiple prescriptions taken:
  • Oxacillin
Patient was hospitalized.

Pyrexia, Tremor
Adverse event was reported on Jan 17, 2012 by a Female taking Dextrose 5% (Dosage: N/A) was diagnosed with and. Location: BRAZIL , child 4 years of age, weighting 26.46 lb, After Dextrose was administered, patient encountered several Dextrose side effects: pyrexia, tremor.
Multiple concurrent drugs taken:
  • Cefuroxime
Patient was hospitalized.

Dyspnoea, Oedema Mouth, Local Swelling
on Jan 06, 2012 Male from AUSTRALIA , 70 years of age, was treated with Dextrose. Directly after, patient experienced the unwanted or unexpected Dextrose side effects: dyspnoea, oedema mouth, local swelling. Dextrose dosage: N/A.
Associated medications used:
  • Capecitabine
  • Oxaliplatin (4th Cycle: 130 Mg/m^2, Intravenous Drip)


Oedema Mouth, Dyspnoea, Localised Oedema
on Jan 11, 2012 Male from AUSTRALIA , 70 years of age, was treated with Dextrose 5%. Patient felt the following Dextrose side effects: oedema mouth, dyspnoea, localised oedema. Dextrose 5% dosage: N/A.
Multiple prescriptions taken:
  • Oxaliplatin


Colitis Ulcerative, Gastrointestinal Haemorrhage
Patient was taking Dextrose+nacl+kcl. After Dextrose was administered, patient encountered several Dextrose side effects: colitis ulcerative, gastrointestinal haemorrhage on Dec 20, 2011 from UNITED STATES Additional patient health information: Female , weighting 129.2 lb, . Dextrose+nacl+kcl dosage: N/A.
Multiple concurrent drugs taken:
  • Rocuronium Bromide
  • Bentyl
  • Azithromycin
  • Amoxicillin
  • Simethicone
  • Zydone
  • Benadryl
  • 5% Dextrose In 0.45% Normal Saline
Patient was hospitalized.

Disease Complication
Adverse event was reported on Dec 19, 2011 by a Female taking Dextrose 10% (Dosage: N/A) was diagnosed with and. Location: AUSTRALIA , 67 years of age, Directly after, patient experienced the unwanted or unexpected Dextrose side effects: disease complication.
Associated medications used:
  • Travasol 10% W/ Electrolytes
  • Clinoleic 20%


Dyspnoea, Cardiac Failure Congestive
on Dec 15, 2011 Male from UNITED STATES , weighting 216.1 lb, was treated with Dextrose W/nitroglycerine. Patient felt the following Dextrose side effects: dyspnoea, cardiac failure congestive. Dextrose W/nitroglycerine dosage: N/A.
Multiple prescriptions taken:
  • Dianeal
Patient was hospitalized.

Fall, Blood Glucose Increased, Upper Limb Fracture
on Nov 21, 2011 Female from UNITED STATES , 62 years of age, weighting 250.5 lb, was treated with Dextrose. After Dextrose was administered, patient encountered several Dextrose side effects: fall, blood glucose increased, upper limb fracture. Dextrose dosage: 2x.
Multiple concurrent drugs taken:
  • Lantus (Dose:50 Unit(s))
  • Simvastatin
  • Lantus (30-40 Units Daily, Also Reported As 40-50 Units Daily)
  • Levothyroxine Sodium
  • Solostar
  • Valsartan
  • Sulindac (2 Daily)
  • Amlodipine Besylate


Colon Cancer Metastatic, Hyperammonaemia, Hepatic Failure, Condition Aggravated, Venous Thrombosis
Patient was taking Dextrose In Lactated Ringer's. Directly after, patient experienced the unwanted or unexpected Dextrose side effects: colon cancer metastatic, hyperammonaemia, hepatic failure, condition aggravated, venous thrombosis on Nov 16, 2011 from JAPAN Additional patient health information: Female , 34 years of age, weighting 123.5 lb, . Dextrose In Lactated Ringer's dosage: N/A.
Associated medications used:
  • Avastin
  • Kytril
  • Lasix
  • Bifidobacterium Bifidum/enterococcus Faecium
  • Magnesium Oxide
  • Fluorouracil
  • Dexamethasone Sodium Phosphate
  • Primperan Tab
Patient was hospitalized.

Pyrexia, Tremor
Adverse event was reported on Nov 01, 2011 by a Female taking Dextrose 5% (Dosage: N/A) was diagnosed with and. Location: BRAZIL , child 6 years of age, weighting 46.30 lb, Patient felt the following Dextrose side effects: pyrexia, tremor. Patient was hospitalized.

Pyrexia, Tremor
on Nov 01, 2011 Male from BRAZIL , child 10 years of age, weighting 85.98 lb, was diagnosed with and was treated with Dextrose 5%. After Dextrose was administered, patient encountered several Dextrose side effects: pyrexia, tremor. Dextrose 5% dosage: N/A. Patient was hospitalized.

Tremor, Pyrexia
on Nov 01, 2011 Female from BRAZIL , child 4 years of age, weighting 26.46 lb, was diagnosed with and was treated with Dextrose 5%. Directly after, patient experienced the unwanted or unexpected Dextrose side effects: tremor, pyrexia. Dextrose 5% dosage: N/A. Patient was hospitalized.

1 of 8 

Keep Track of Side Effects

Note Your Observations

It is really important to keep of your symptoms, right from the time you start a new medicine. You can do it any way you prefer: in a notebook, in a computer file or using our online tool. You should also note down any other medicines you are taking at the same time, because there could be an interaction between these medicines.

Why Your Notes are Important

Your notes could be helpful in several ways:

  • You can use them to remind you of details that may alert your health care professional(s) to a problem
  • You will have a record to refer to in the future, in case you are ever prescribed the same medicine again
  • Log Form

    You can use the following log form to write down important information, like the date and time you experienced a side effect and your symptoms, how strong the symptoms were, and any other medicines you were using.

    Medicine Name and Dosage:

     

    Side Effects

    Scale

    Date & Time

    Other Medicine(s) or Treatment(s)

     

     

     

     

    Scale: 1 = very mild to 10 = very bad

    Track Online

  • User Sign In
  • Register to track your side effects
  • You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.

    Discuss Dextrose Side Effects

    Did You Have a Dextrose Side Effect?

    Yes, Severe
    Yes, Moderate
    Yes, Minor
    No

    How Effective is Dextrose for You?

    Exceeded Expectations
    Effective
    Somewhat Effective
    Not Effective

    Safety Alerts, Active Ingredients, Usage Information

    DEXTRAN 4 SODIUM LA

    Active Ingredient: ADENINE; ANHYDROUS CALCIUM C DEXTRAN 4 DEXTROSE DEXTROSE;

    Dextrose Dosage, Warnings, Usage.

    Side Effects reported to FDA: 189

    Dextrose safety alerts: 2014 2013 2012 2008

    Reported deaths: 9

    Reported hospitalizations: 50

    Lactated Ringers and 5 Percent Dextrose Injection, USP, 1000 ML, Flexible Containers: Recall - Due to Non-Sterility

    [Posted 01/28/2013]

    AUDIENCE: Pharmacy, Patient, Health Professional

    ISSUE: Hospira, Inc. is initiating a voluntary nationwide user-level recall of one lot of Lactated Ringers and 5% Dextrose Injection, USP, 1000 mL, Flexible Container, NDC 0409-7929-09. This action is due to one confirmed customer report where a spore-like structured particulate, consistent with mold, was noted in the solution. Hospira has not received reports of any adverse events associated with this issue for this lot, and has not identified any quality issues with retention samples for this lot. If contaminated solution is used on a patient, this may cause thrombosis, phlebitis, bacteremia, sepsis, septic shock and/or endocarditis, or result in a fatal infection in a broad array of patients.

    BACKGROUND: The product is used as a source of water, electrolytes and calories or as an alkalizing agent and is packaged in a 1000 mL flexible container, lot number 05-019-JT, with an expiration date of May 1, 2013. The affected lot was distributed nationwide between June 2011 and January 2012 to wholesalers/distributors, hospitals and pharmacies.

    RECOMMENDATION: Anyone with an existing inventory should stop use and distribution, quarantine the product immediately, and call Stericycle at 1-888-965-5798 between the hours of 8am to 5pm EST, Monday through Friday, to arrange for the return of the product. Replacement product from other lots is available. For medical inquiries, please contact Hospira Medical Communications at 1-800-615-0187.

    Healthcare professionals and patients are encouraged to report adverse events or side effects related to the use of these products to the FDA's MedWatch Safety Information and Adverse Event Reporting Program:

    • Complete and submit the report Online: www.fda.gov/MedWatch/report.htm
    • Download form or call 1-800-332-1088 to request a reporting form, then complete and return to the address on the pre-addressed form, or submit by fax to 1-800-FDA-0178

    [01/25/2013 - Firm Press Release - Hospira, Inc]

    Latest Dextrose clinical trials